EP0462111A4 - Homing sequences and their uses - Google Patents

Homing sequences and their uses

Info

Publication number
EP0462111A4
EP0462111A4 EP19900902104 EP90902104A EP0462111A4 EP 0462111 A4 EP0462111 A4 EP 0462111A4 EP 19900902104 EP19900902104 EP 19900902104 EP 90902104 A EP90902104 A EP 90902104A EP 0462111 A4 EP0462111 A4 EP 0462111A4
Authority
EP
European Patent Office
Prior art keywords
homing sequences
homing
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900902104
Other versions
EP0462111A1 (en
Inventor
Irving L. Weissman
Bernard Holzmann
Mark H. Siegelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of EP0462111A1 publication Critical patent/EP0462111A1/en
Publication of EP0462111A4 publication Critical patent/EP0462111A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP19900902104 1988-12-23 1989-11-10 Homing sequences and their uses Withdrawn EP0462111A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28920188A 1988-12-23 1988-12-23
US289201 1988-12-23
US31573689A 1989-02-24 1989-02-24
US315736 1989-02-24

Publications (2)

Publication Number Publication Date
EP0462111A1 EP0462111A1 (en) 1991-12-27
EP0462111A4 true EP0462111A4 (en) 1992-07-08

Family

ID=26965504

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900902104 Withdrawn EP0462111A4 (en) 1988-12-23 1989-11-10 Homing sequences and their uses

Country Status (3)

Country Link
EP (1) EP0462111A4 (en)
JP (1) JPH04504501A (en)
WO (1) WO1990007321A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
US7238668B1 (en) 1989-09-01 2007-07-03 Fred Hutchinson Cancer Research Center Inhibition of lymphocyte adherence with CS-1-peptides and fragments thereof
US7750137B2 (en) 1995-09-01 2010-07-06 Millennium Pharmaceuticals, Inc. Mucosal vascular addressins
US7803904B2 (en) 1995-09-01 2010-09-28 Millennium Pharmaceuticals, Inc. Mucosal vascular addressing and uses thereof
US6551593B1 (en) 1995-02-10 2003-04-22 Millennium Pharmaceuticals, Inc. Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US7147851B1 (en) 1996-08-15 2006-12-12 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with α4β7 integrin
US6111090A (en) * 1996-08-16 2000-08-29 Schering Corporation Mammalian cell surface antigens; related reagents
CN103212071B (en) * 2005-08-25 2017-12-12 亚利桑那大学董事会 Stem cell fusion model of carcinogenesis
UA116189C2 (en) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. FORMULATION FOR ANTI-α4β7 ANTIBODY
PE20141672A1 (en) 2011-05-02 2014-11-26 Millennium Pharm Inc FORMULATION FOR ANTI-alpha4�7 ANTIBODY

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303463A2 (en) * 1987-08-11 1989-02-15 The Board Of Trustees Of The Leland Stanford Junior University Method to control leukocyte extravasation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303463A2 (en) * 1987-08-11 1989-02-15 The Board Of Trustees Of The Leland Stanford Junior University Method to control leukocyte extravasation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9007321A3 *

Also Published As

Publication number Publication date
JPH04504501A (en) 1992-08-13
WO1990007321A2 (en) 1990-07-12
WO1990007321A3 (en) 2010-05-27
EP0462111A1 (en) 1991-12-27

Similar Documents

Publication Publication Date Title
GB8919556D0 (en) Periscope
GB2210043B (en) Phosphinylcycloalkylcarbonyl and phosphinylcycloalkenylcarbonyl dipeptides
GB2218786B (en) Arrow gun
EP0413084A3 (en) Projectile
EP0462111A4 (en) Homing sequences and their uses
GB2284251B (en) Projectile
GB8914067D0 (en) Projectile
GB8918252D0 (en) Armour
ZW10789A1 (en) Primer
YU2589A (en) Improved hide
GB2313435A8 (en) Field howitzers
GB2222511B (en) Body armour
IL89599A0 (en) Armor
GB8817747D0 (en) Firearms
GB2215014B (en) Short range projectile
GB8819841D0 (en) Shooting facility
GB8914921D0 (en) Projectile
ZA898616B (en) Primer
BG47144A1 (en) Experimental projectile
GB8805539D0 (en) Missiles
GB8814439D0 (en) Weapons
ZA90343B (en) Weapon
GB8819965D0 (en) Improved projectile
ZA893162B (en) Environmental chamber and construction thereof
IE882564L (en) Pyridobenzoxazines and pyridobenzothiazines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910627

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB LI

A4 Supplementary search report drawn up and despatched

Effective date: 19920521

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB LI

17Q First examination report despatched

Effective date: 19931125

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960103